Literature DB >> 11435931

Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death.

T Hosoda1, H Nakajima, H Honjo.   

Abstract

Accumulating studies have shown that estrogen replacement therapy reduces the risk of Alzheimer's disease. In this study, we clarified that 17beta-estradiol (E2) significantly rescues PC12 neuronal cells from amyloid beta protein (Abeta)-induced cell death. We found that the amino acid residues of 25 to 35 (Abeta25-35) were more cytotoxic than the full length protein (Abeta1-40) and these residues induced DNA fragmentation typical for apopto- sis. In addition, E2 was confirmed to inhibit calcium influx and cytochrome c release induced by Abeta25-35. Since these sequential events cause apoptosis, the protective effect of E2 may be exerted not by the direct interaction with Abeta, but by the blockade of the mitochondrial apoptotic pathway induced by Abeta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435931     DOI: 10.1097/00001756-200107030-00038

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

1.  ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling.

Authors:  Sheila M Adams; Marina V Aksenova; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  Synapse       Date:  2010-11       Impact factor: 2.562

Review 2.  Actions and interactions of estradiol and glucocorticoids in cognition and the brain: Implications for aging women.

Authors:  Alexandra Ycaza Herrera; Mara Mather
Journal:  Neurosci Biobehav Rev       Date:  2015-04-27       Impact factor: 8.989

3.  STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.

Authors:  Nora E Gray; Jonathan A Zweig; Colleen Kawamoto; Joseph F Quinn; Philip F Copenhaver
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 4.  Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Biochim Biophys Acta       Date:  2009-07-16

5.  The potential for estrogens in preventing Alzheimer's disease and vascular dementia.

Authors:  James W Simpkins; Evelyn Perez; Xiaofei Wang; Shaohua Yang; Yi Wen; Meharvan Singh
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

6.  Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis.

Authors:  Bruce F Bebo; Babak Dehghani; Scott Foster; Astrid Kurniawan; Francisco J Lopez; Larry S Sherman
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

7.  Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?

Authors:  Marià Alemany
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

Review 8.  Epidemiology of estrogen and dementia in women with Down syndrome.

Authors:  Nicole Schupf; Joseph H Lee; Deborah Pang; Warren B Zigman; Benjamin Tycko; Sharon Krinsky-McHale; Wayne Silverman
Journal:  Free Radic Biol Med       Date:  2017-08-31       Impact factor: 8.101

9.  Yizhijiannao Granule and a combination of its effective monomers, icariin and Panax notoginseng saponins, inhibit early PC12 cell apoptosis induced by beta-amyloid (25-35).

Authors:  Ting Zhang; Zhanwei Zhang; Keli Dong; Guangcheng Li; Hong Zhu
Journal:  Neural Regen Res       Date:  2012-08-25       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.